Adenosine. Pharmacology
The adenosine is an endogenous purine nucleoside with multiple functions in the body. In the cardiovascular system it acts mainly as a modulator of conduction and vascular tone.
Mechanism of Action
- It acts on type A1 adenosine receptors in the atrioventricular node (AVN), causing transient inhibition of conduction through this node.
- It induces hyperpolarisation of nodal cells by opening potassium channels (IKAdo) and reducing calcium influx, which interrupts reentry in AVN-dependent tachycardias.
- It also stimulates A2A receptors in the vascular endothelium, causing coronary vasodilatation, which explains the transient flushing and chest tightness.

Pharmacokinetics
- Half-life: Extremely short (less than 10 seconds) because it is rapidly broken down by adenosine deaminase in blood and red blood cells.
- Administration: Intravenous as a rapid bolus, followed by a saline flush to make sure it reaches the heart immediately.
- Onset of action: Less than 5 seconds.
- Duration of effect: Usually less than 30 seconds.
Side Effects
Because its action is transient, adverse effects are usually brief and self-limiting. The most common include:
✔ Facial flushing (due to transient vasodilatation).
✔ Chest tightness (not related to myocardial ischaemia).
✔ Dyspnoea or bronchospasm (can be severe in patients with asthma or COPD).
✔ Nausea or dizziness.
✔ Transient asystole followed by return of normal sinus rhythm.
Contraindications
⚠ Second- or third-degree AV block without a pacemaker.
⚠ Sick sinus syndrome without a pacemaker.
⚠ Severe asthma or COPD (risk of bronchospasm).
⚠ Atrial fibrillation with pre-excitation (e.g. Wolff-Parkinson-White syndrome), as it can induce a rapid ventricular response and cause ventricular fibrillation.
To learn more about the possible ECG responses to adenosine, see this post.






